Literature DB >> 9525710

Magnetic resonance imaging-documented extravasation as an indicator of acute hypertensive intracerebral hemorrhage.

Y Murai1, Y Ikeda, A Teramoto, Y Tsuji.   

Abstract

OBJECT: The aim of this study was to determine the usefulness of magnetic resonance (MR) imaging-documented extravasation as an indicator of continued hemorrhage in patients with acute hypertensive intracerebral hemorrhage (ICH).
METHODS: The authors studied 108 patients with acute hyperintensive ICH. Imaging modalities included noncontrast-enhanced computerized tomography (CT) scanning, gadolinium-enhanced MR imaging, and conventional cerebral angiography obtained within 6 hours after the onset of hemorrhage. A repeated CT scan was obtained within 48 hours to evaluate enlargement of the hematoma. Findings on MR imaging indicating extravasation, including any high-intensity signals on T1-weighted postcontrast images, were observed in 39 patients, and 17 of these also showed evidence of extravasation on cerebral angiography. The presence of extravasation on MR imaging was closely correlated with evidence of hematoma enlargement on follow-up CT scans (p < 0.001).
CONCLUSIONS: Evidence of extravasation documented on MR imaging indicates persistent hemorrhage and correlates with enlargement of the hematoma.

Entities:  

Mesh:

Year:  1998        PMID: 9525710     DOI: 10.3171/jns.1998.88.4.0650

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  An in vivo, MRI-integrated real-time model of active contrast extravasation in acute intracerebral hemorrhage.

Authors:  R I Aviv; T Huynh; Y Huang; D Ramsay; P Van Slyke; D Dumont; P Asmah; R Alkins; R Liu; K Hynynen
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-24       Impact factor: 3.825

2.  Contrast extravasation through MRI precedes cerebral hemorrhage in a patient with eclampsia.

Authors:  Mikel Terceño; Joaquín Serena; Irene Bragado; Yolanda Silva
Journal:  Neurol Sci       Date:  2016-11-24       Impact factor: 3.307

3.  Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption.

Authors:  C S Kidwell; R Burgess; R Menon; S Warach; L L Latour
Journal:  Neurology       Date:  2011-10-26       Impact factor: 9.910

Review 4.  What does the CT angiography "spot sign" of intracerebral hemorrhage mean in modern neurosurgical settings with minimally invasive endoscopic techniques?

Authors:  Toru Nagasaka; Suguru Inao; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2012-12-16       Impact factor: 3.042

5.  "Dynamic spot sign" on CT perfusion source images predicts haematoma expansion in acute intracerebral haemorrhage.

Authors:  Sheng-Jun Sun; Pei-Yi Gao; Bin-Bin Sui; Xin-Yi Hou; Yan Lin; Jing Xue; Ren-You Zhai
Journal:  Eur Radiol       Date:  2013-03-19       Impact factor: 5.315

Review 6.  European research priorities for intracerebral haemorrhage.

Authors:  Thorsten Steiner; Jesper Petersson; Rustam Al-Shahi Salman; Hanne Christensen; Charlotte Cordonnier; Laszlo Csiba; Sagi Harnof; Derk Krieger; David Mendelow; Carlos Molina; Joan Montaner; Karsten Overgaard; Risto O Roine; Erich Schmutzhard; Turgut Tatlisumak; Danilo Toni; Christian Stapf
Journal:  Cerebrovasc Dis       Date:  2011-10-08       Impact factor: 2.762

Review 7.  Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage.

Authors:  Richard F Keep; Ningna Zhou; Jianming Xiang; Anuska V Andjelkovic; Ya Hua; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2014-08-10

8.  Prolonged Blood-Brain Barrier Injury Occurs After Experimental Intracerebral Hemorrhage and Is Not Acutely Associated with Additional Bleeding.

Authors:  Colby A Nadeau; Kristen Dietrich; Cassandra M Wilkinson; Andrew M Crawford; Graham N George; Helen K Nichol; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2018-06-14       Impact factor: 6.829

Review 9.  Revisiting Minocycline in Intracerebral Hemorrhage: Mechanisms and Clinical Translation.

Authors:  Ruiyi Zhang; V Wee Yong; Mengzhou Xue
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.